Lipigon Pharmaceuticals AB (publ)

OM:LPGO BTA Stock Report

Market Cap: SEK 24.9m

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Lipigon Pharmaceuticals Management

Management criteria checks 0/4

Key information

Stefan Nilsson

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure6.5yrs
CEO ownershipn/a
Management average tenureno data
Board average tenureless than a year

Recent management updates

No updates

Recent updates

CEO

Stefan Nilsson (43 yo)

6.5yrs
Tenure

Dr. Stefan K. Nilsson serves as the Chief Executive Officer of Lipigon Pharmaceuticals AB since 2016. Dr. Nilsson is an entrepreneur and Co-Founder of Lipigon. Dr. Nilsson has been central in all Lipigon’s...

Board Members

NamePositionTenureCompensationOwnership
Lars Öhman
Business Development Manager & Chairmanless than a yearno datano data
Gunilla Olivecrona
Co-founder & Board Memberno datano datano data
Urban Paulsson
Independent Directorno datano datano data
Jessica Martinsson
Board Member1.2yrsno datano data
Johannes Hulthe
Board Member1.5yrsno datano data
Maj Hedtjarn
Scientific Advisorno datano datano data
Ludger Scheja
Scientific Advisorno datano datano data
Sander Kersten
Scientific Advisorno datano datano data
Troels Koch
Scientific Advisorno datano datano data
Jorg Heeren
Scientific Advisorno datano datano data
Eva Lindqvist
Independent Directorless than a yearno datano data
0.8yrs
Average Tenure
59yo
Average Age

Experienced Board: LPGO BTA's board of directors are not considered experienced ( 0.8 years average tenure), which suggests a new board.

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2022/07/17 13:16
End of Day Share Price 2022/07/14 00:00
Earnings2022/03/31
Annual Earnings2021/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Lipigon Pharmaceuticals AB (publ) is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Carl RamaniusRedeye